The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 3, 1999, Pages 760-761

  Bloch, Mark ^a   Carr, Andrew ^b   Vasak, Eva ^b   Cunningham, Phillip ^b   Smith, Don ^c,d  

^a Holdsworth House General Practice   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d Community HIV Research Network ^*  (Australia)

Author keywords

Antiretrovirals; Artificial insemination; Human immunodeficiency virus; Prophylaxis

Indexed keywords

ANTIRETROVIRUS AGENT; CHORIONIC GONADOTROPIN; INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; ARTIFICIAL INSEMINATION; CASE REPORT; DOSE RESPONSE; FEMALE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHADENITIS; NEPHROLITHIASIS; PRIORITY JOURNAL; PROPHYLAXIS; RASH; SEROCONVERSION; VIRUS TRANSMISSION;

EID: 0032828637     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70529-6     Document Type: Article

References (3)

1. 1. Wortley PM, Hammett TA, Fleming PL. Donor insemination and human immunodeficiency virus transmission. Obstet Gynecol 1998;91:515-8.
2. 2. Stewart GJ, Cunningham AL, Driscoll GL, et al. Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor. Lancet 1985;2:581-5.
3. 2. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR Morb Mortal Wkly Rep 1996;45:468-80.